Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study

AIMS: The international IMPROVE™ observational study investigated the safety profile and effectiveness of biphasic insulin aspart 30/70 (BIAsp 30) in the routine treatment of patients with type 2 diabetes. We present analyses for the subgroup of patients who switched from basal insulin to BIAsp 30....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gumprecht, J, Benroubi, M, Borzi, V, Kawamori, R, Shaban, J, Shah, S, Shestakova, M, Wenying, Y, Ligthelm, R, Valensi, P
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2009
Assuntos:
Late Breakers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2734926/
https://ncbi.nlm.nih.gov/pubmed/19504715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-1241.2009.02064.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados